Blinded sample size recalculation in clinical trials with binary composite endpoints

References

• Birkett, M. A., Day, S. D. (1994). Internal pilot studies for estimating sample size. Statistics in Medicine 13:2455–2463.
   PubMed Web of Science ®Google Scholar
• CHMP. (2007). Reflection paper on methodological issues in confirmatory clinical trials planned with an adaptive design. CHMP/EWP/2459/02.
   Google Scholar
• Cook, J. A., Hislop, J., Altman, D. G., Fayers, P., Briggs, A. H., Ramsay, C. R., Norrie, J. D., Harvey, I. M., Buckley, B., Fergusson, D., Ford, I., Vale, L. D., for the DELTA group (2015). Specifying the target difference in the primary outcome for a randomised controlled trial: Guidance for researchers. Trials 16:12.
   PubMed Web of Science ®Google Scholar
• Einarson, T. R., Garg, M., Kaur, V., Hemels, M. E. H. (2014). Composite endpoints in trials of type-2 diabetes. Diabetes, Obesity and Metabolism 16:492–499.
   PubMed Web of Science ®Google Scholar
• Fayers, P. M., Cuschieri, A., Fielding, J., Craven, J., Uscinska, B., Freedman, L. S. (2000). Sample size calculation for clinical trials: The impact of clinician beliefs. British Journal of Cancer 82:213–219.
   PubMed Web of Science ®Google Scholar
• FDA. (2010). Guidance for industry: Adaptive Design Clinical Trials for Drugs and Biologics. Available at: http://www.fda.gov (accessed30 July 2015).
   Google Scholar
• Ferreira-González, I., Busse, J. W., Heels-Ansdell, D., Montori, V. M., Akl, E. A., Bryant, D. M., Alonso-Coello, P., Alonso, J., Worster, A., Upadhye, S., Jaeschke, R., Schuenemann, H. J., Permanyer-Miralda, G., Pacheco-Huergo, V., Domingo-Salvany, A., Wu, P., Mills, E. J., Guyatt, G. H. (2007). Problems with use of composite end points in cardiovascular trials: Systematic review of randomised controlled trials. British Medical Journal 34:786.
   Google Scholar
• Friede, T., Kieser, M. (2004). Sample size recalculation for binary data in internal pilot study designs. Pharmaceutical Statistics 3:269–279.
   Web of Science ®Google Scholar
• Friede, T., Kieser, M. (2006). Sample size recalculation in internal pilot study designs: A review. Biometrical Journal 48:537–555.
   PubMed Web of Science ®Google Scholar
• Friede, T., Kieser, M. (2011). Sample size reassessment in non-inferiority trials. Internal pilot study designs with ANCOVA. Methods of Information in Medicine 50:237–243.
   PubMed Web of Science ®Google Scholar
• Friede, T., Kieser, M. (2013). Blinded sample size re-estimation in superiority and noninferiority trials: Bias versus variance in variance estimation. Pharmaceutical Statistics 12:141–146.
   PubMed Web of Science ®Google Scholar
• Friede, T., Mitchell, C., Mueller-Velten, G. (2007). Blinded sample size reestimation in non-inferiority trials with binary endpoints. Biometrical Journal 49:903–916.
   PubMed Web of Science ®Google Scholar
• Friede, T., Schmidli, H. (2010). Blinded sample size reestimation with count data: Methods and applications in multiple sclerosis. Statistics in Medicine 29:1145–1156.
   PubMed Web of Science ®Google Scholar
• Golkowski, D., Friede, T., Kieser, M. (2014). Blinded sample size re-estimation in crossover bioequivalence trials. Pharmaceutical Statistics 13:157–162.
   PubMed Web of Science ®Google Scholar
• Gould, A. L. (1992a). Interim analyses for monitoring clinical trials that do not materially affect the type I error rate. Statistics in Medicine 11:55–66.
   PubMed Web of Science ®Google Scholar
• Gould, A. L., Shih, W. J. (1992b). Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance. Communications in Statistics: Theory and Methods 21:2833–2853.
   Web of Science ®Google Scholar
• ICH E9 Expert Working Group. (1999). Statistical principles for clinical trials: ICH harmonized tripartite guideline. Statistics in Medicine 18:1905–1942.
   Google Scholar
• Ingel, K., Jahn-Eimermacher, A. (2014). Sample-size calculation and reestimation for a semiparametric analysis of recurrent event data taking robust standard errors into account. Biometrical Journal 56:631–648.
   PubMed Web of Science ®Google Scholar
• Kieser, M., Friede, T. (2000). Re-calculating the sample size in internal pilot study designs with control of the type I error rate. Statistics in Medicine 19:901–911.
   PubMed Web of Science ®Google Scholar
• Kieser, M., Friede, T. (2003). Simple procedures for blinded sample size adjustment that do not affect the type I error rate. Statistics in Medicine 22:3571–3581.
   PubMed Web of Science ®Google Scholar
• Maechler, M. (2014). Rmpfr: R MPFR - Multiple Precision Floating-Point Reliable. R package version 0.5–7. http://CRAN.R-project.org/package=Rmpfr
   Google Scholar
• Neaton, J. D., Gray, G., Zuckerman, B. D., Konstam, M. A. (2005). Key issues in end point selection for heart failure trials: Composite end points. Journal of Cardiac Failure 11:567–575.
   PubMed Web of Science ®Google Scholar
• Rauch, G., Kieser, M. (2012). Multiplicity adjustment for composite binary endpoints. Methods of Information in Medicine 51:309–317.
   PubMed Web of Science ®Google Scholar
• Rauch, G., Rauch, B., Schueler, S., Kieser, M. (2015). Opportunities and challenges of clinical trials in cardiology using composite primary endpoints. World Journal of Cardiology 7:1–5.
   Web of Science ®Google Scholar
• R Core Team. (2014). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-project.org/.
   Google Scholar
• Schneider, S., Schmidli, H., Friede, T. (2013). Blinded and unblinded internal pilot study designs for clinical trials with count data. Biometrical Journal 55:617–633.
   PubMed Web of Science ®Google Scholar
• Sozu, T., Sugimoto, T., Hamasaki, T. (2010). Sample size determination in clinical trials with multiple co-primary endpoints. Statistics in Medicine 29:2169–2179.
   PubMed Web of Science ®Google Scholar
• Stone, G. W., Ellis, S. G., Cox, D. A., Hermiller, J., O’Shaughnessy, C., Mann, J. T., Turco, M., Caputo, R., Bergin, P., Greenberg, J., Popma, J. J., Russell, M. E., for the TAXUS-IV Investigators (2004). A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. New England Journal of Medicine 350:221–223.
   Google Scholar
• Stone, G. W., Ellis, S. G., Cannon, L., Mann, J. T., Greenberg, J. D., Spriggs, D., O’Shaughnessy, C. D., DeMaio, S., Hall, P., Popma, J. J., Koglin, J., Russell, M. E., TAXUS V Investigators (2005). Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized controlled trial. The Journal of the American Medical Association 294:1215–1223.
   PubMed Web of Science ®Google Scholar
• Wachtlin, D., Kieser, M. (2013). Blinded sample size recalculation in longitudinal clinical trials using generalized estimating equations. Therapeutic Innovation & Regulatory Science 47:460–467.
   Web of Science ®Google Scholar
• Wittes, J., Brittain, E. (1990). The role of internal pilot studies in increasing the efficiency of clinical trials. Statistics in Medicine 9:65–71.
   PubMed Web of Science ®Google Scholar
• Wuest, K., Kieser, M. (2005). Including long- and short-term data in blinded sample size recalculation for binary endpoints. Computational Statistics & Data Analysis 48:835–855.
   Web of Science ®Google Scholar
• Zucker, D. M., Wittes, J. T., Schabenberger, O., Brittain, E. (1999). Internal pilot studies II: Comparison of various procedures. Statistics in Medicine 18:3493–3509.
   PubMed Web of Science ®Google Scholar